Log in
Enquire now
‌

US Patent 9975897 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase

Patent 9975897 was granted and assigned to Loxo Oncology on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Loxo Oncology
Loxo Oncology
Current Assignee
Loxo Oncology
Loxo Oncology
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9975897
Patent Inventor Names
Nicolas E. S. Guisot0
Mathew Calder0
Date of Patent
May 22, 2018
Patent Application Number
15317323
Date Filed
June 11, 2015
Patent Primary Examiner
‌
Susanna Moore
Patent abstract

This invention relates to compounds of formula (I). The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9975897 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us